Abstract To investigate the role in lipoprotein metabolism of lipoprotein lipase (LPL) secreted by tissues, we established two cell lines. Fusion plasmids containing either human LPL cDNA or antisense LPL cDNA under control of the cytomegalovirus promoter were transfected into Chinese hamster ovary (CHO) cells, designated as CHO-LPL and CHO-anti-LPL, respectively. CHO-LPL constitutively produced a high level of LPL, whereas CHO-anti-LPL produced a minimal level. When very-low-density lipoprotein (VLDL) was incubated with CHO-LPL, VLDL triglycerides were hydrolyzed, intermediate-density lipoprotein (IDL) was produced, and apolipoprotein E contents increased. CHO-LPL took up and degraded 125 I-VLDL at 37°C four times more strongly than did CHO-anti-LPL. Whereas the degradation of apolipoprotein E-deficient VLDL was only 12% that of normal VLDL in CHO-LPL, structural changes of the lipoprotein, including apolipoprotein E expression on the lipoprotein surface, may be important for the cellular uptake of VLDL. Furthermore, we found that binding at 4°C of VLDL and LDL to CHO-LPL was greater than to CHO-anti-LPL, and this binding difference was abolished by washing the cells with heparin. This suggests that cell surface LPL plays a role in the binding of lipoproteins to the cells. We conclude that both the composition of VLDL particles and their cellular binding are influenced by LPL secreted by cells, both of which may enhance the cellular uptake of VLDL. (Arterioscler Thromb. 1994;14:235-242.) Key Words • lipoprotein lipase • transfection • VLDL • LDL L ipoprotein lipase (LPL) plays a central role in the metabolism of lipoproteins rich in triglycerides, such as chylomicrons and very-low-density lipoproteins (VLDLs). LPL is a glycoprotein synthesized in most extrahepatic tissues and is bound to heparan sulfate on the capillary endothelial cell surface.
I-VLDL at 37°C four times more strongly than did CHO-anti-LPL. Whereas the degradation of apolipoprotein E-deficient VLDL was only 12% that of normal VLDL in CHO-LPL, structural changes of the lipoprotein, including apolipoprotein E expression on the lipoprotein surface, may be important for the cellular uptake of VLDL. Furthermore, we found that binding at 4°C of VLDL and LDL to CHO-LPL was greater than to CHO-anti-LPL, and this binding difference was abolished by washing the cells with heparin. This suggests that cell surface LPL plays a role in the binding of lipoproteins to the cells. We conclude that both the composition of VLDL particles and their cellular binding are influenced by LPL secreted by cells, both of which may enhance the cellular uptake of VLDL. . LPL is a glycoprotein synthesized in most extrahepatic tissues and is bound to heparan sulfate on the capillary endothelial cell surface. 12 LPL determines the rate of production of low-density lipoproteins (LDLs) in plasma through the VLDL-intermediate-density lipoprotein (IDL)-LDL cascade by hydrolyzing triglyceride in lipoproteins. 34 After the hydrolysis of triglycerides, the liberated free fatty acids are supplied to the tissues, including adipose tissue, heart, and muscle.
Many studies using purified LPL have suggested that the cellular uptake of triglyceride-rich lipoproteins is enhanced in vitro by LPL. 59 It is suggested that after hydrolysis of VLDL triglyceride, exposure of unreactive apolipoprotein (apo) E 5 and conformational changes in apo B-100 7 enhance binding of VLDL to LDL receptors. Furthermore, recent studies have reported that LPL mediates LDL binding to cell surface heparan sulfate proteoglycans, thereby increasing cellular uptake of LDL. 810 We have reported that both apo E and LPL secreted by human monocyte-derived macrophages enhance the uptake of VLDL. 11 To clarify the significance of these proteins for VLDL uptake, we established two cell lines that secrete either apo E or LPL and reported Received August 24, 1993 ; revision accepted October 29, 1993 . From the Third Department of Internal Medicine, University of Tokyo, Tokyo, Japan.
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that apo E molecules secreted by Chinese hamster ovary (CHO) cells are transferred to VLDL and enhance the uptake of these particles. 12 In the present study, we investigated the roles of LPL in the uptake of VLDL as well as its hydrolysis using a cell model that produces a high level of human LPL. To do so, we established a cell line that produces a minimal level of LPL by transfecting antisense LPL cDNA as a negative control, because CHO cells normally secrete LPL.
Methods Materials
Wild-type Chinese hamster ovary (CHO-K) cells were purchased from the American Type Culture Collection (Rockville, Md). [
Northern blot analysis of total RNA. Chinese hamster ovary (CHO) cells were cultured, and total RNAs (10 yug) were prepared by extraction with acid guanidinium thiocyanate, phenol, and chloroform. Total RNA was subjected to agarose gel electrophoresis, then transferred to nylon membranes, and hybridized with a cDNA probe for human lipoprotein lipase (LPL). The filter was washed, air-dried, and autoradiographed for 1 day.
the experiment, VLDL was dialyzed extensively against PBS. Lipoproteins were iodinated by a modification of the iodine monochloride method. 15 
Cell Culture and Gene Transfection
CHO-K cells were maintained in HAM F12 medium containing 10% NCS in humidified 5% CO 2 incubators at 37°C. Plasmid pCMV-LPL and plasmid pCMV-LPL-antisense in which human LPL cDNA was fused to the Rc/CMV vector cytomegalovirus (CMV) (Invitrogen, San Diego, Calif) were used for the gene transfection to CHO-K cells. 16 In the case of plasmid pCMV-LPL-antisense, LPL cDNA was inserted into the vector in the antisense orientation.
CHO-K cells were seeded at 2.8 x 10 6 cells per 6 -cm dish and cultured in HAM F12 with 10% NCS for 24 hours. Twentyfour hours before transfection, the medium was changed to Dulbecco's modified Eagle's medium (DMEM) with 10% FCS. DNA-calcium phosphate coprecipitates were prepared as follows 1216 -17 : 250 /AL of the solution containing 8.8 ^.g DNA of either pCMV-LPL or pCMV-LPL-antisense and 250 mmol/L CaCl 2 was added dropwise to the same volume of 2x Hanks' buffered saline (HBS) (280 mmol/L NaCl, 50 mmol/L HEPES, 1.5 mmol/L Na 2 HPO 4 , and 12 mmol/L dextrose, pH 7.0), and the mixture was kept at room temperature for 30 minutes. Then the mixture was added to each medium and incubated for 4 hours. The cells were washed once with PBS without CaCl 2 and shocked for 90 seconds with 15% glycerol in 1 x HBS. The cells were washed with PBS and allowed to grow for an additional 24 hours in HAM F12 with 10% NCS. At this time, the cells were subcultured and diluted 1:5 in the complete medium supplemented with 600 /xg/mL of G418. After 3 weeks of G418 selection, resistant colonies were selected and cultured in DMEM with 10% FCS. The conditioned medium was screened by measurement of LPL activity. Strong positive and negative clones were designated as CHO-LPL and CHO-anti-LPL, respectively. LPL activity and mass were measured as previously described. 1618 Lipase activity was estimated from the amount of free oleic acid that was liberated from Chinese hamster ovary (CHO)-lipoprotein lipase (LPL), CHOanti-LPL, and CHO-K cells were seeded at 2 . 0 X 1 0 6 cells per 6-cm dish and cultured in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal calf serum. While subconfluent (usually 2 to 3 days after seeding), the medium was changed to DMEM with 5 mg/mL lipoprotein-deficient serum and incubated further for 24 hours. Then, 100 tig protein/mL VLDL was incubated with the cells for 4 hours, and lipoproteins in the medium were isolated by density-gradient ultracentrifugation in a Beckman SW-41 rotor at 40 000 rpm for 22 hours at 12°C. The density gradient was made by a stepwise compilement of three different density layers (top, d=1.00; middle, d = 1.0315; bottom, d=1.063 g/mL). The volume of each layer was 3.7 mL, and the bottom layer contained 1 mL of the sample medium. After ultracentrifugation, seven fractions from the top to the bottom were isolated, and the salt concentration, as determined by an electric conductivity meter, was used to calculate the density of each fraction. The results were expressed as mean of two experiments.
30-minute incubation, and 1 nmol free fatty acid per hour per milligram cell protein was expressed as 1 unit of LPL activity. Various amounts of VLDL were incubated with the transfectants (l.Ox 10 5 cells per well of 12-wel! plates) for the indicated hours at 37°C. The concentrations of triglycerides and cholesterol in the culture medium were measured enzymatically, and the VLDL ultracentrifugally separated from the culture medium was subjected to 3% to 20% sodium dodecyl sulfate gradient polyacrylamide gel electrophoresis. 19 To study VLDL lipolysis during the culture, the culture medium was analyzed by density-gradient ultracentrifugation 20 and gel filtration chromatography 21 as previously described.
Preparation of RNA and Northern Blotting
Total cellular RNA was prepared by extraction with acid guanidinium thiocyanate, phenol, and chloroform as described. 22 Total RNA (10 ^.g) was subjected to electrophoresis in formaldehyde-agarose (1%) gel and transferred to a nylon , CHO-anti-LPL, and CHO-K cells were seeded at 2.0x10 6 cells per 6-cm dish and cultured in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal calf serum. While subconfluent (usually 2 to 3 days after seeding), the medium was changed to DMEM with 5 mg/mL lipoprotein-deficient serum and incubated further for 24 hours. Then, 100 ^g protein/mL VLDL was incubated with the cells for 8 hours, and 100 fit of the medium was applied to a column of TSK G3000SW (Tosoh). The effluent was monitored at 280 nm and was combined with an enzymatic reagent for measurement of cholesterol or triglycerides at a rate of 0.25 mL/min. Enzymatic reaction was performed in a Teflon tube in a temperature-controlled bath, and the final effluent was monitored at 550 nm. The results were expressed as mean of two experiments. LDL indicates low-density lipoprotein; HDL, highdensity lipoprotein.
membrane. The filter was baked, prehybridized, and hybridized with the probe for human LPL cDNA, which was labeled with [ 32 P]dCTP by the random-primer method according to the manufacturer's protocol. 23 The filter was washed, air-dried, and autoradiographed for 1 day. The conditions for hybridization and washing were as described.
24
Binding Assay for LDL Receptor CHO-LPL, CHO-anti-LPL, and CHO-K cells were seeded at l.OxlO 5 cells per 2.2-cm well and cultured in DMEM with 10% FCS. While subconfluent (usually 2 to 3 days after seeding), the medium was changed to DMEM with 5 mg/mL lipoprotein-deficient serum and incubated further for 24 hours. Then, iodinated lipoproteins were added to the medium to yield the indicated concentrations, and the cell association and degradation of iodinated VLDL at 37°C were measured as described. 2526 Nonspecific cell association and degradation were estimated in the presence of a 50-fold excess of either unlabeled VLDL or LDL. The incubation period was 5 hours, and the cell association at 37°C included both surface-bound and internalized 125 I-lipoproteins. To measure binding at 4°C, the cells were incubated with a medium containing 125 I-labeled lipoproteins at 4°C for 2 hours and thereafter washed once rapidly and twice for 10 minutes with a buffer containing 50 mmol/L Tris-HCl, 150 mmol/L NaCl, and 2 mg/mL BSA, pH 7.4. Cells were dissolved in 0.1N NaOH, and their radioactivities were counted in a gamma counter. The concentrations of cell proteins dissolved in 0.1N NaOH were determined by the method of Lowry et al. 27 
Results

Selection of Transfectants
We selected two transfectant clones after assaying their LPL activities and masses in both medium and cells that were incubated for 24 hours at 37°C in the absence of heparin. In CHO-LPL and CHO-anti-LPL cells, cellular LPL activities were 4696 ±976 (n=6) and 284 ±116 (n=6) U/d, and LPL activities in the medium were 5004±845 (n=12) and 242±151 (n=7) U/d, respectively, whereas LPL activities in CHO-K cells and medium were 475 ±142 (n=6) and 642 ±204 (n=12) U/d, respectively. LPL masses in the media of CHO-K, CHO-LPL, and CHO-anti-LPL were 74.9±19.6 (n=8), 631.5±72.6 (n=8), and 17.4±7.9 (n=7) ng/mg cell protein per day, and those in cells were 151.3±62. 
Hydrolysis of VLDL
When 100 /xg/mL normal VLDL was incubated with each of three different cell types, a time-related decrease in triglyceride concentration was found in each of the three cell types, and the decrease was least in CHO-anti-LPL cells (Fig 2) . The amount of triglyceride remaining in VLDL in the medium of CHO-LPL cells was 33% of that in the medium of CHO-anti-LPL cells after an 8-hour incubation. We observed a slight change in cholesterol concentration in the media of these three cell types. Dose-related changes in triglyceride concentrations were demonstrated in the medium of CHO-LPL cells when incubated for 8 hours with various amounts of VLDL (Fig 2) .
The VLDL incubated with CHO-LPL cells for 4 hours at 37°C was subjected to density-gradient ultracentrifugation, and we found a decrease in the d-1.005 fraction and increases in the d=1.017 and d= 1.029 fractions compared with control VLDL, indicating that lipolytic conversion of VLDL occurred in the medium of CHO-LPL cells. In contrast, no significant change was found in VLDL incubated with CHO-anti-LPL cells (Fig 3) . Furthermore, we evaluated the elution profile of VLDL by gel filtration chromatography. As shown in 6 cells per 6-cm dish and cultured in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal calf serum. While subconfluent (usually 2 to 3 days after seeding), the medium was changed to DMEM with 5 mg/mL lipoprotein-deficient serum and incubated further for 24 hours. Then, 100 ^g protein/mL VLDL was incubated with the cells for 8 hours, and 2 mL of the medium was ultracentrifuged in a Beckman SW 41 rotor at 38 000 rpm at 12°C for 22 hours to reisolate VLDL. The VLDL (20 ng protein) was subjected to sodium dodecyl sulfate 3% to 20% gradient polyacrylamide gel electrophoresis. The gel was stained with Coomassie brilliant blue, and the ratio of apoliprotein (apo) E to apo C was estimated from their intensities by densitometric scan.
incubated with CHO-anti-LPL cells among the three different cell types. A similar result was obtained in experiments using hypertriglyceridemic VLDL.
The change in VLDL apolipoproteins was analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and we observed the ratio of apo E to apo C. As shown in Fig 5, the apo E content in VLDL incubated with CHO-LPL cells was greater than with CHO-anti-LPL. The analysis of densitometric scanning demonstrated that the ratio of apo E to apo C of VLDL incubated with CHO-LPL cells was 3.8-fold greater than with CHO-anti-LPL cells (0.614 versus 0.162).
Cellular Uptake of VLDL
We studied the uptake of normal VLDL and hypertriglyceridemic VLDL in three different cell types. In experiments using normal VLDL, the degradation of VLDL was fourfold to fivefold greater in CHO-LPL cells than in both CHO-LPL and CHO-anti-LPL cells (Fig 6, left) . We could not find any significant difference in the degradation of VLDL between CHO-K and CHO-anti-LPL cells (Fig 6, left) . When we used hypertriglyceridemic VLDL, there was a difference in the degradation of VLDL between CHO-K and CHO-anti-LPL cells. The degradation of hypertriglyceridemic VLDL was greater in CHO-K cells than in CHO-anti- Hypertriglyceridemic VLDL
VLDL-protein (ng/ml) VLDL-protein (ug/ml) FIG 6. Graphs showing binding assay of very-low-density lipoprotein (VLDL) to transfectants. Chinese hamster ovary (CHO)-lipoprotein lipase (LPL)
, CHO-anti-LPL, and CHO-K cells were seeded at 1 .Ox 10 5 cells per 2.2-cm well and cultured in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal calf serum. While subconfluent (usually 2 to 3 days after seeding), the medium was changed to DMEM with 5 mg/mL lipoprotein-deficient serum and incubated further for 24 hours. Then, the indicated amounts of either 125 l-normal VLDL (left) or hypertriglyceridemic VLDL (right) were added to the medium, and the cell association and degradation of iodinated VLDL at 37°C were measured. Nonspecific cell association and degradation were estimated in the presence of a 50-fold excess of unlabeled VLDL. The incubation period was 5 hours. The results of normal VLDL (left) were expressed as mean±SD of three experiments, and those of hypertriglyceridemic VLDL (right) were expressed as mean±SD of four experiments. Each measurement was performed in triplicate or quadruplicate.
LPL cells (Fig 6, right) . As shown in Fig 7, excess VLDL completely suppressed the degradation of VLDL in all three cell types, whereas the suppression of VLDL degradation in the presence of excess LDL was incomplete. To study the effect of apo E on the degradation of VLDL, we observed the degradation of VLDL isolated from subjects with apo E deficiency and type III hyperlipoproteinemia (E2/2 phenotype) and compared the results with those seen with normal VLDL. In CHO-LPL cells, these three VLDLs were degraded, and the degradations of apo E-deficient VLDL and E2/2 VLDL were 12% and 22% that of normal VLDL, as shown in Table 1 . No degradation or minimal degradation of apo E-deficient VLDL and E2/2 VLDL was observed in CHO-anti-LPL cells.
We performed assays of VLDL binding at 4°C to both CHO-LPL and CHO-anti-LPL cells. VLDL binding to CHO-LPL cells (n=3) was 2.3-fold greater than that to CHO-anti-LPL cells (n=3), whereas after heparin washing of those cells, no difference was observed in the binding of VLDL to either cell line ( Table 2 ), indicating that cellular binding of VLDL was mediated by cell surface LPL. Conversely, degradation at 37°C of VLDL to CHO-LPL cells (n=7) was 4.1-fold greater than to CHO-anti-LPL cells (n=7). We suggest that the difference between 4°C binding and 37°C degradation resulted from lipolytic change of VLDL caused by the action of LPL. LDL binding at 4°C was similar for the two cell types after heparin washing, whereas it was twofold greater in CHO-LPL cells than in CHO-anti-LPL cells in the absence of heparin (Table 2) . To observe the effect of heparin on the release of LPL from cell surface, we measured LPL activities in the presence and absence of heparin. As shown in Fig 8, heparin treatment immediately increased LPL activity in the culture medium.
Discussion
In the present study, we investigated the effect of LPL secreted by CHO cells transfected with human LPL cDNA on lipoprotein metabolism. It has recently been reported that the LPL gene is expressed in CHO cells, 28 suggesting that results of studies of lipoprotein metabolism using CHO cells have been influenced to some extent by the LPL that is secreted constitutively by CHO cells. Human monocyte-derived macrophages and mouse peritoneal macrophages are also known to secrete LPL, 2930 and we reported previously that LPL 2-cm well and cultured in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal calf serum. While subconfluent (usually 2 to 3 days after seeding), the medium was changed to DMEM with 5 mg/mL lipoproteindeficient serum and incubated further for 24 hours. Then, the indicated amounts of 125 l-normal VLDL were added to the medium, and the cell association and degradation of 125 I-VLDL at 37°C were determined in the presence and absence of either a 50-fold excess of unlabeled VLDL or low-density lipoprotein (LDL). The incubation period was 5 hours. The results were expressed as mean of two experiments. Each measurement was performed in quadruplicate.
secreted from macrophages is important in the uptake of VLDL. 11 In the present study, we established two different LPL transfectants -one overexpressing and the other minimally expressing. To obtain a highly expressive transfectant, we constructed a CMV promoter-human LPL fusion gene. For a negative control, CHO-anti-LPL cells were produced by transfection with the antisense cDNA of LPL. We found high LPL activity in the medium of CHO-LPL cells and almost no activity in the medium of CHO-anti-LPL cells.
Many studies using purified LPL have indicated that the cellular uptake of triglyceride-rich lipoproteins is enhanced in vitro by LPL. 58 In the present study, we demonstrated that LPL influences the uptake of VLDL, using a cell culture system that is a more physiological model of in vivo cell/lipoprotein interaction than are systems that use purified LPL. In a 125 I-VLDL binding assay at 37°C, both uptake and degradation of VLDL were significantly enhanced in CHO-LPL cells com- Then, 5 ixglmL of iodinated VLDL isolated from either a normolipidemic subject with E3/3, a subject with E2/2, or a subject with apolipoprotein E deficiency was added to the medium, and specific cell association and degradation of iodinated VLDL at 37°C were measured. Each experiment was performed in quadruplicate.
pared with CHO-anti-LPL cells. Even in CHO-K cells, which secrete LPL, VLDL uptake was greater than in CHO-anti-LPL cells, particularly when hypertriglyceridemic VLDL was used. A similar effect of LPL on LDL binding was observed in CHO-LPL cells. The increased binding of VLDL hydrolyzed by LPL was explained mainly by two different mechanisms. One was that LDL receptor-dependent uptake of those lipoproteins was enhanced, and the other was that the LDL receptorindependent pathway was enhanced. If the former process is the sole mechanism by which the VLDL uptake by CHO-LPL cells is increased, uptake should be abolished by an excess of LDL. However, excess LDL could not completely inhibit VLDL uptake by both CHO-LPL and CHO-anti-LPL cells. The uptake of VLDL in the presence of excess LDL may be mediated by LDL receptor-independent pathways.
Mechanisms of LDL receptor-dependent uptake of VLDL by CHO-LPL cells may involve hydrolysis of VLDL, which induces conformational changes in lipoproteins that may expose the receptor binding domain of apo E 5 and apo B-100, 7 thereby enhancing their binding to LDL receptors. In fact, the structure of VLDL was modified significantly by LPL secreted from CHO-LPL cells compared with CHO-anti-LPL cells. VLDL triglycerides were hydrolyzed, IDLs and LDLs were produced, and the relative apo E content increased during the incubation of VLDL with CHO-LPL cells, whereas no significant structural changes were observed in VLDL incubated with CHO-anti-LPL cells. Furthermore, the low uptake of apo E-deficient VLDL in culture with CHO-LPL cells indicated the importance of apo E in the receptor-mediated uptake of normal VLDL. The uptake of apo E-deficient VLDL may be mediated through the interaction of apo B-100 with the LDL receptor or through another pathway.
The increased uptake of VLDL by CHO-LPL cells may have been caused by an increase in the expression of LDL receptors on CHO-LPL cells, which may have resulted from the transfection of the LPL gene; however, it is rare that transfection of one gene influences the expression of another gene. This possibility can be ruled out by the experiment of lipoprotein binding carried out at 4°C because neither LPL secretion nor modification of lipoproteins occurs at 4°C. In the absence of heparin, VLDL binding to CHO-LPL cells was significantly greater than to CHO-anti-LPL cells, whereas after the cells were washed with heparin, there was no significant difference in VLDL binding between the two cell types. This result suggests that the cellular binding of VLDL before heparin washing was influenced by a substance released or blocked by heparin treatment. Since the most significant difference between the two cell types was the expression of LPL, it must be LPL that is released from the cell surface after heparin treatment. 3133 In fact, we have observed that LPL activity in culture medium increases significantly immediately after heparin treatment, as shown in Fig 8. The VLDL binding to CHO-LPL cells at 4°C before heparin treatment was 2.3-fold greater than to CHO-anti-LPL cells, whereas degradation at 37°C of VLDL was 4.1-fold greater to CHO-LPL cells than to CHO-anti-LPL cells. We speculate that lipolysis of VLDL caused by the action of LPL at 37°C yielded the difference in VLDL binding observed between 4°C and 37°C experiments.
Lipoprotein uptake can be mediated through LDL receptor-independent pathways, and it is suggested that one of the pathways is mediated by LPL. The hypothesis that LPL acts as a bridge between lipoproteins and cell surface heparan sulfate proteoglycans to which LPL binds has been proposed by several groups.
810 -31 -3435 A recent study suggested that LPL promotes binding of apo B-100-rich lipoproteins, including LDL and lipoprotein^), to cell surface proteoglycans, thereby increasing cellular degradation of those lipoproteins through an LDL receptor-independent pathway. 810 Similarly, in our study, we demonstrated increased binding of LDL at 4°C and increased uptake of LDL at 37°C by CHO-LPL cells. This LPL-mediated lipoprotein uptake may be also involved in the uptake of apo E-deficient VLDL by CHO-LPL cells. A suppression of both VLDL and LDL binding to CHO-LPL cells at 4°C in the presence of heparin further supported this hypothesis. Furthermore, another recent report suggested that LPL enhances the binding of apo E-rich lipoproteins to LDL receptor-related protein because both LPL and apo E-rich lipoproteins bind to the LDL receptor-related protein. 36 This process may be involved in the uptake of hydrolyzed VLDL, which contains more apo E than does native VLDL.
In the present study, we produced two cell strains that constitutively secreted LPL at high or minimal levels. Using these cell strains, we established the hypothesis that LPL plays a significant role not only in the lipolysis of VLDL but also in the ceiiuiar uptake of lipoproteins. Binding studies of lipoproteins suggested that the increased cellular uptake of VLDL by CHO-LPL cells is mediated by two different pathways -an LDL receptordependent pathway involving the binding of lipolyzed VLDL and an LDL receptor-independent pathway involving the binding of lipoproteins containing apo B-100 to LPL. LPL may help regulate lipid metabolism in tissues as a multifunctional protein. It may act as both an enzyme and a bridge protein connecting lipoproteins with cell surface heparan sulfate proteoglycans. We recently reported that overexpression of LPL acts to protect against diet-induced hypertriglyceridemia as well as hypercholesterolemia in a study using transgenic mice, indicating that LPL regulates both plasma triglyceride and cholesterol metabolism. 37 Taken together, LPL may regulate not only plasma triglyceride levels by hydrolyzing lipoprotein triglycerides but also plasma cholesterol levels by modifying cellular uptake of lipoproteins containing apo B-100.
